Search Result

Isoforms Recommended:	CK1

Results for "

CK1

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Adenosine Kinase (2) Amyloid-β (1) Apoptosis (8) Autophagy (2) Biochemical Assay Reagents (1) c-Myc (1) Casein Kinase (81) CDK (8) Checkpoint Kinase (Chk) (1) E3 Ligase Ligand-Linker Conjugates (1) Early 2 Factor (E2F) (1) ERK (1) GSK-3 (1) IKZF Family (3) Ligands for E3 Ligase (1) Ligands for Target Protein for PROTAC (1) MALT1 (1) MDM-2/p53 (2) Molecular Glues (13) p38 MAPK (9) Phosphodiesterase (PDE) (2) PI3K (7) Porcupine (1) PROTACs (1) Ribosomal S6 Kinase (RSK) (2) SGK (2) Small Interfering RNA (siRNA) (3) VEGFR (1) Wnt (7)
By Research Areas:	Cancer (57) Cardiovascular Disease (3) Infection (1) Inflammation/Immunology (6) Metabolic Disease (3) Neurological Disease (23)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (2) siRNAs (3)

Inhibitors & Agonists

Peptides

Natural
Products

Recombinant Proteins

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-111820

CK1-IN-1	Casein Kinase p38 MAPK	Cardiovascular Disease
CK1-IN-1 (Compound 1c) is a casein kinase 1 (CK1) inhibitor with IC₅₀ values of 15 nM and 16 nM for CK1δ and CK1ε, respectively. CK1-IN-1 inhibits p38α MAPK with an IC₅₀ of 73 nM. CK1-IN-1 can be used to study cardiomyogenesis ^[1].

HY-153866

CK1-IN-2	Casein Kinase	Cancer
CK1-IN-2 (compound Nr.4) is a potent *CK1* inhibitor with an IC₅₀ values of 123, 19.8, 26.8, 74.3 nM for CK1a, CK1d, CK1e, p38a, respectively ^[1].

HY-128433

CK1-IN-3	Casein Kinase	Neurological Disease
CK1-IN-3 (compound 51) is a *AC1* inhibitor with an IC₅₀s 2.22 µM for CK-1δ ^[1] .

HY-P10606

CK1tide	Biochemical Assay Reagents	Others
CK1tide is a substrate for casein kinase 1 (CK1) and can be used to assess CK1's in vitro catalytic activity by detecting whether CK1 can phosphorylate it ^[1].

HY-153866A

CK1-IN-2 hydrochloride	Casein Kinase	Cancer
CK1-IN-2 (compound Nr.4) hydrochloride is a potent *CK1* inhibitor with an IC₅₀ values of 123, 19.8, 26.8, 74.3 nM for CK1a, CK1d, CK1e, p38a, respectively ^[1].

HY-162756

CK1-IN-4	Casein Kinase	Neurological Disease
CK1-IN-4 (Compound 59) is an inhibitor for casein kinase *CK1δ* with IC₅₀ of 2.74 μM. CK1-IN-4 exhibits neuroprotective effect in Ethacrynic acid (HY-B1640)-treated SH-SY5Y cells ^[1].

HY-170860

CK1δ/CK1ε liagnd-1	Casein Kinase Ligands for Target Protein for PROTAC	Cancer
CK1δ/CK1ε liagnd-1 is the ligand for *CK1δ/CK1ε* that can be used for synthesis of CK1 PROTAC degrader AH078 (HY-170859) as the ligand for target protein ^[1].

HY-W842364

CK1δ-IN-3	Casein Kinase	Neurological Disease
CK1δ-IN-3 (compound 376) is a casein kinase 1δ (CK1δ) inhibitor. CK1δ-IN-3 can be utilized in neurodegenerative disorders research ^[1].

HY-169713

CK1δ-IN-5	Casein Kinase	Neurological Disease
CK1δ-IN-5 (Compound 24) is a Casein kinase 1δ (CK1δ) inhibitor. CK1δ-IN-5 can be used in the research of neurodegenerative diseases ^[1].

HY-169719

CK1δ-IN-6	Casein Kinase	Neurological Disease
CK1δ-IN-6 (Compound 303) is a Casein kinase 1δ inhibitor. CK1δ-IN-6 is promising for research of Alzheimer's disease ^[1].

HY-171292

CK1δ-IN-9	Casein Kinase p38 MAPK	Others
CK1δ-IN-9 (Compound 8) is the inhibitor for casein kinase 1 that inhibits *CK1δ* with IC₅₀ of 1.4 nM. CK1δ-IN-9 inhibits p38α and p38β with IC₅₀ of 0.25 μM and 0.78 μM. CK1δ-IN-9 exhibits pharmacokinetic characteristics with a good oral bioavailability (70%) and a moderate clearance ^[1].

HY-169556

CK1δ-IN-7	Casein Kinase	Neurological Disease
CK1δ-IN-7 (Compound 488) is the inhibitor for casein kinase 1δ (CK1δ) ^[1].

HY-W840382

CK1δ-IN-8	Casein Kinase	Neurological Disease
CK1δ-IN-8 (Compound 429) is a *CK1δ* inhibitor that can be used in Alzheimer's disease research ^[1].

HY-171298

CK1δ-IN-10	Casein Kinase	Neurological Disease Metabolic Disease Cancer
CK1δ-IN-10 (Compound 85) is the inhibitor for casein kinase 1 that inhibits *CK1δ* (CSNKID) with IC₅₀ of 0.255 μM ^[1].

HY-160532

CK1α degrader-1	Casein Kinase	Cancer
CK1α degrader-1 (Compound 82) is an orally active *CK1α* degrader with a DC₅₀ of 0.105 μM. CK1α degrader-1 can be used for the research of cancer ^[1].

HY-P11119

CKS peptide	Casein Kinase	Neurological Disease
CKS peptide is a selective substrate peptide for *CK1. CKS peptide can used to measure CK1* activity ^[1].

HY-158975

*VRK1/CK1-IN-1*	Casein Kinase	Cancer
VRK1/CK1-IN-1 (compound 36) is a dual inhibitor of vaccinia-related kinase 1 (VRK1) and casein kinase 1 (CK1), with the K_i of 37.9 nM for VRK1 and IC₅₀s of 17 nM and 15 nM for δ and ε isoforms of *CK1*, respectively ^[1].

HY-114858

Epiblastin A	Casein Kinase	Cancer
Epiblastin A is an ATP competitive casein kinase 1 (CK1) inhibitor with IC₅₀s of 8.9, 0.5, and 4.7 µM for CK1α, CK1δ, and CK1 ɛ, respectively. Epiblastin A induces reprogramming of epiblast stem cells into embryonic stem cells by inhibition of CK1 ^[1].

HY-103383

(R)-DRF053 dihydrochloride	CDK Casein Kinase	Neurological Disease Cancer
(R)-DRF053 dihydrochloride is a potent casein kinases 1 (CK1), CDK1/cyclin B and CDK5/p25 inhibitor with IC₅₀s of 14 nM, 220 nM and 80 nM, respectively. (R)-DRF053 dihydrochloride prevents the CK1-dependent production of amyloid-beta in a cell model ^[1].

HY-P5526

CCK1-specific peptide substrate	Casein Kinase	Others
CCK1-specific peptide substrate is a biological active peptide. (This peptide sequence is based on rabbit muscle glycogen synthase with Ser7 phosphorylated. It is a peptide substrate for Casein Kinase I (CK1). CK1 phosphorylates Ser10. Ser7 is phosphorylated by PKA in vivo.)

HY-10324

D4476 5+ Cited Publications Casein Kinase I Inhibitor	Casein Kinase Autophagy Apoptosis	Cancer
D4476 is a potent, selective and cell-permeable inhibitor of casein kinase 1(CK1) with an IC₅₀ value of 0.3 μM in vitro.

HY-108442

JW67 1 Publications Verification	Wnt	Cancer
JW67 inhibits the canonical Wnt signaling with an IC₅₀ of 1.17μM ^[1]. JW67 affects the multiprotein complex consisting of β-catenin/GSK-3β/AXIN/APC/CK1 that rapidly reduces active β-catenin with a subsequent downregulation of Wnt target genes. JW67 also inhibits colorectal cancer cell growth ^[1].

HY-12470

PF-4800567 2 Publications Verification	Casein Kinase	Others
PF-4800567 is a potent and selective inhibitor of casein kinase 1? (CK1?), with an IC₅₀ of 32 nM, which is greater than 20-fold selectivity over CK1δ (IC₅₀, 711 nM).

HY-100114

TA-01	Casein Kinase p38 MAPK Autophagy	Cardiovascular Disease
TA-01 is a potent *CK1* and p38 MAPK inhibitor, with IC₅₀s of 6.4 nM, 6.8 nM, 6.7 nM for CK1ε, CK1δ and p38 MAPK, respectively. TA-01 acts as a cardiogenic inhibitor.

HY-12774

IC261 4 Publications Verification	Casein Kinase Apoptosis	Cancer
IC261 is a selective, ATP-competitive *CK1* inhibitor, with IC₅₀s of 1 μM, 1 μM, 16 μM for Ckiδ, Ckiε and Ckiα1, respectively.

HY-110052

TBCA 1 Publications Verification	Casein Kinase	Cancer
TBCA is a highly selective CK2 (casein kinase II) inhibitor with an IC₅₀ of 110 nM and a K_i of 77 nM. TBCA shows selectivity for CK2 over CK1, DYRK1A and a panel of 27 other kinases ^[1] .

HY-W011109

CKI-7	Casein Kinase CDK SGK Ribosomal S6 Kinase (RSK)	Cancer
CKI-7 is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC₅₀ of 6 μM and a K_i of 8.5 μM. CKI-7 is a selective Cdc7 kinase inhibitor. CKI-7 also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 has a much weaker effect on casein kinase II and other protein kinases ^[1] .

HY-12470A

PF-4800567 hydrochloride	Casein Kinase	Cancer
PF-4800567 hydrochloride is a potent and selective inhibitor of?casein kinase?1? (CK1?), with an?IC₅₀?of 32 nM, which is greater than 20-fold selectivity over CK1δ (IC50, 711 nM). PF-4800567 hydrochloride is useful in probing unique roles between these two kinases in multiple signaling pathways ^[1].

HY-117857

MRT00033659	Casein Kinase Checkpoint Kinase (Chk) MDM-2/p53 Early 2 Factor (E2F)	Cancer
MRT00033659 is a potent broad-spectrum kinase inhibitor of *CK1* (IC₅₀=0.9 μM for CK1δ) and *CHK1* (IC₅₀=0.23 μM). MRT00033659, a pyrazolo-pyridine analogue, induces p53 pathway activation and E2F-1 destabilisation ^[1].

HY-133028

CKI-7 free base 1 Publications Verification	Casein Kinase CDK SGK Ribosomal S6 Kinase (RSK)	Cancer
CKI-7 free base is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC₅₀ of 6 μM and a K_i of 8.5 μM. CKI-7 free base is a selective Cdc7 kinase inhibitor. CKI-7 free base also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 free base has a much weaker effect on casein kinase II and other protein kinases ^[1] .

HY-15424

5-Iodotubercidin 5+ Cited Publications NSC 113939; 5-ITu	Adenosine Kinase	Cancer
5-Iodotubercidin (NSC 113939), an ATP mimetic, is a potent adenosine kinase inhibitor with an IC₅₀ of 26 nM. 5-Iodotubercidin (NSC 113939) initiates glycogen synthesis in isolated hepatocytes by causing inactivation of phosphorylase and activation of glycogen synthase. 5-Iodotubercidin (NSC 113939) also inhibits CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2, PKC and Haspin ^[1] .

HY-15424R

5-Iodotubercidin (Standard)	Adenosine Kinase	Cancer
5-Iodotubercidin (Standard) is the analytical standard of 5-Iodotubercidin. This product is intended for research and analytical applications. 5-Iodotubercidin (NSC 113939), an ATP mimetic, is a potent adenosine kinase inhibitor with an IC50 of 26 nM. 5-Iodotubercidin (NSC 113939) initiates glycogen synthesis in isolated hepatocytes by causing inactivation of phosphorylase and activation of glycogen synthase. 5-Iodotubercidin (NSC 113939) also inhibits CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2, PKC and Haspin ^[1] .

HY-173494

*GSK-3β/CK-1δ-IN-1*	GSK-3 Casein Kinase	Cancer
GSK-3β/CK-1δ-IN-1 (8d) is a dual and blood-brain barrier penetrated GSK-3β / *CK-1δ* inhibitor, with IC₅₀ values of 0.77 μM for GSK-3β and 0.57 μM for CK-1δ, respectively. GSK-3β/CK-1δ-IN-1 (8d) can be used in the research for neuroblastoma ^[1].

HY-171301

*p38α MAPK/CK1δ inhibitor-1*	p38 MAPK Casein Kinase	Inflammation/Immunology
p38α MAPK/CK1δ inhibitor-1 (Compound 3) exhibits inhibitory activity against p38α MAPK and *CK1δ* with IC₅₀s of 0.185 µM and 0.089 µM ^[1].

HY-RS23603

Csnk1a1 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Csnk1a1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Csnk1a1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Csnk1a1 Rat Pre-designed siRNA Set A Csnk1a1 Rat Pre-designed siRNA Set A

HY-148251

MU1742	Casein Kinase	Cancer
MU1742 is a probe for *CK1δ* and *CK1ε* protein kinases ^[1].

HY-18285

Longdaysin	Wnt Casein Kinase ERK CDK	Cancer
Longdaysin is a inhibitor of the Wnt/β-catenin signaling pathway, which exerts antitumor effect through blocking CK1δ/ε-dependent Wnt signaling. Longdaysin inhibits *CK1α, CK1δ, CDK7, and ERK2* with IC₅₀s of 5.6 µM, 8.8 µM, 29 µM, and 52 µM, respectively ^[1] .

HY-170859

AH078	Casein Kinase	Others
AH078 (compound 37) is a PROTAC degrader that selectively targets CK1δ and CK1ε, and has low targeting for CK1α. AH078 consists of PROTAC linker (black part) Monomethyl octanoate (HY-W001958), target protein ligand (red part) (HY-170860) CK1δ/CK1ε liagnd-1 and E3 ligase ligand (blue part) E3 ligase Ligand 58 (HY-170861). Among them, E3 ligase ligand + linker can form a conjugate E3 Ligase Ligand-linker Conjugate 163 (HY-170862) ^[1].

HY-15490

PF-670462 dihydrochloride 5+ Cited Publications	Casein Kinase	Cancer
PF-670462 dihydrochloride is a potent and selective inhibitor of casein kinase (CK1ε and CK1δ), with IC₅₀s of 7.7 nM and 14 nM, respectively.

HY-100536

IWP-3	Wnt	Cancer
IWP-3 is an potent inhibitor of Wnt production with an IC₅₀ of 40 nM. IWP-3 inhibits Porcupine (Porcn) function thereby blocking palmitoylation of Wnt proteins. IWP-3 inhibits CK1γ3 and CK1ε only moderately and does not inhibit CK1α ^[1] .

HY-100011

SR-3029 2 Publications Verification	Casein Kinase	Cancer
SR-3029 is a potent and ATP competitive *CK1δ* and *CK1ε* inhibitor, with IC₅₀s of 44 nM and 260 nM, respectively, and K_is of 97 nM for both kinases.

HY-145939

BAY-888 BRD5846	Casein Kinase	Cancer
BAY-888 is a selective *CK1α/CSNK1A1* (casein kinase 1α) ATP-competitive inhibitor (IC₅₀: 4 nM@10 μM ATP; 63 nM@1 mM ATP). BAY-888 blocks the negative regulation of p53 and other signaling pathways by CK1α, induces apoptosis and inhibits proliferation of tumor cells. BAY-888 has shown inhibitory efficacy against cancers such as acute myeloid leukemia (AML) in PRISM barcoded cell line screening and can mimic the effects of shRNA-mediated CK1α knockdown. BAY-888 is primarily used for the development of anticancer drugs for p53 wild-type tumors and for the study of the mechanisms of CK1α-related signaling pathways ^[1] .

HY-171277

Casein kinase 1δ-IN-27	Casein Kinase p38 MAPK	Cancer
Casein kinase 1δ-IN-27 (Compound 8) is the inhibitor for casein kinase 1 that inhibits *CK1α, CK1δ, CK1ε, and p38α* with IC₅₀s of 22, 16.5, 9.41 and 14.8 nM, respectively. Casein kinase 1δ-IN-27 inhibits the DUX4 expression with an IC₅₀ of 10 nM ^[1].

HY-12443

PF-5006739	Casein Kinase	Neurological Disease
PF-5006739 is a potent and selective inhibitor of *CK1δ/ε* with IC₅₀s of 3.9 nM and 17.0 nM, respectively. PF-5006739 is a potential therapeutic agent for a range of psychiatric disorders with low nanomolar in vitro potency for CK1δ/ε and high kinome selectivity. PF-5006739 attenuats opioid agent-seeking behavior in a rodent operant reinstatement model in animals in a dose-dependent manner ^[1]. PF-5006739 improves glucose tolerance in both diet-induced obesity (DIO) and genetic (ob/ob) mice models of obesity .

HY-170953

QXG-6442	Casein Kinase Molecular Glues	Cancer
QXG-6442 is a *CK1α* Molecular Glue Degrader. QXG-6442 exhibits *CK1α* degradation potency with a DC₅₀ of 5.7 nM and a D_max of 90%. QXG-6442 induces antiproliferative effects in MOLM-14 cell line ^[1].

HY-155958

Casein kinase 1δ-IN-9	Casein Kinase	Neurological Disease
Casein kinase 1δ-IN-9 (compound 737) is a potent casein kinase 1δ (CK1δ/CK15) inhibitor. Casein kinase 1δ-IN-9 can be used for the research of neurodegenerative disorders such as Alzheimer's disease ^[1].

HY-149292

SR-4133	Casein Kinase	Cancer
SR-4133 is a potent and highly *CK1ε* selective inhibitor with an IC₅₀ of 58 nM. SR-4133 binds to the ATP-binding site of CK1ε. SR-4133 displays nanomolar growth inhibition of bladder cancer cells, and inhibits the phosphorylation of 4E-BP1 ^[1].

HY-145322

TMX-4116	Casein Kinase Molecular Glues	Cancer
TMX-4116 is a casein kinase 1α (CK1α) degrader. TMX-4116 shows the degradation preference for CK1α with DC₅₀s less than 200 nM in MOLT4, Jurkat, and MM.1S cells. TMX-4116 can be used for the research of multiple myeloma ^[1].

HY-153904

Casein kinase 1δ-IN-5	Casein Kinase	Neurological Disease
Casein kinase 1δ-IN-5 is a potent and selective protein kinase *CK-1δ* inhibitor with an IC₅₀ of 47 nM. Casein kinase 1δ-IN-5 shows neuroprotective and anti-inflammatory properties both in vitro. Casein kinase 1δ-IN-5 has the potential for neurodegenerative diseases research.

HY-170862

E3 Ligase Ligand-linker Conjugate 163	E3 Ligase Ligand-Linker Conjugates	Cancer
E3 Ligase Ligand-linker Conjugate 163 is the E3 ligase ligand (E3 ligase Ligand 58, HY-170861)-linker conjugate part of AH078 (HY-170859). AH078 is a PROTAC that targets the degradation of *CK1δ* and *CK1ε*, and can be used for research related to circadian rhythm disorders ^[1].

Cat. No.	Product Name	Target	Research Area

HY-P10606

CK1tide	Biochemical Assay Reagents	Others
CK1tide is a substrate for casein kinase 1 (CK1) and can be used to assess CK1's in vitro catalytic activity by detecting whether CK1 can phosphorylate it ^[1].

HY-P11119

CKS peptide	Casein Kinase	Neurological Disease
CKS peptide is a selective substrate peptide for *CK1. CKS peptide can used to measure CK1* activity ^[1].

HY-P5526

CCK1-specific peptide substrate	Casein Kinase	Others
CCK1-specific peptide substrate is a biological active peptide. (This peptide sequence is based on rabbit muscle glycogen synthase with Ser7 phosphorylated. It is a peptide substrate for Casein Kinase I (CK1). CK1 phosphorylates Ser10. Ser7 is phosphorylated by PKA in vivo.)

Species:	Human (12)
Tag:	His (6) Tag Free (1) Strep (1) GST (6)
Source:	Sf9 insect cells (9) E. coli (3)

Cat. No.	Compare	Product Name	Species	Source

HY-P72152

	CSNK1E Protein, Human (His) Casein kinase 1 epsilon; Casein kinase I; Casein kinase I epsilon; Casein kinase I isoform epsilon; CKI epsilon; CKI-epsilon; CKIe; CKIepsilon; CSNK 1E; CSNK1E; DBT; Doubletime, Drosophila, homolog of; EC 2.7.11.1; epsilon isoform; HCK IE; KC1E; KC1E_HUMAN; kinase CK1 epsilon; MGC 10398	Human	E. coli
	CSNK1E protein is a casein kinase that preferentially phosphorylates acidic proteins such as casein. CSNK1E Protein, Human (His) is the recombinant human-derived CSNK1E protein, expressed by E. coli , with N-6*His labeled tag.

HY-P72759

	MIP-4/CCL18 Protein, Human (His) C-C motif chemokine 18; AMAC-1; DC-CK1; MIP-4; CCL18; PARC; SCYA18	Human	E. coli
	MIP-4/CCL18 Protein, Human (His) is a CC chemokine ligand that binds to PITPNM3, GPR30 and CCR8 receptors and also acts as a neutral CCR3 antagonist mediating inflammation, autoimmunity and carcinogenesis. MIP-4/CCL18 Protein, Human (His) is a recombinant human MIP-4/CCL18 (A21-A89) protein expressed by E. coli with a his tag at N end.

HY-P701659

	CK1γ3 Protein, Human (sf9) CSNK1G3; Casein kinase I isoform gamma-3; CKI-gamma 3	Human	Sf9 insect cells
	The CK1γ3 protein is a serine/threonine protein kinase in the casein kinase family that prefers acidic proteins, including casein. It has broad substrate specificity and can phosphorylate a variety of proteins, affecting diverse cellular processes. CK1γ3 Protein, Human (sf9) is the recombinant human-derived CK1γ3 protein, expressed by sf9 insect cells , with tag free.

HY-P701658

	CK1d Protein, Human (sf9, GST) CSNK1D; Casein kinase I isoform delta; CKI-delta; CKId; Tau-protein kinase CSNK1D	Human	Sf9 insect cells
	The CK1d protein is an important serine/threonine protein kinase that complexly controls cellular processes such as Wnt signaling, DNA repair, and circadian rhythms. Its versatility is evident in phosphorylating a variety of proteins, including connexin-43/GJA1, MAP1A, p53/TP53, and YAP1. CK1d Protein, Human (sf9, GST) is the recombinant human-derived CK1d protein, expressed by sf9 insect cells , with N-GST labeled tag.

HY-P701660

	CK1γ3 Protein, Human (sf9, GST) CSNK1G3; Casein kinase I isoform gamma-3; CKI-gamma 3	Human	Sf9 insect cells
	The CK1γ3 protein is a serine/threonine protein kinase in the casein kinase family that prefers acidic proteins, including casein. It has broad substrate specificity and can phosphorylate a variety of proteins, affecting diverse cellular processes. CK1γ3 Protein, Human (sf9, GST) is the recombinant human-derived CK1γ3 protein, expressed by sf9 insect cells , with N-GST labeled tag.

HY-P72872

	Casein Kinase I alpha Protein, Human (sf9, GST) Casein kinase I isoform alpha; CKI-alpha; CK1; CSNK1A1	Human	Sf9 insect cells
	Casein kinase I α is a member of casein kinases that exhibits a preference for phosphorylation of acidic proteins such as casein. It phosphorylates many substrates, including CTNNB1 at "Ser-45" involved in Wnt signaling. Casein Kinase I alpha Protein, Human (sf9, GST) is the recombinant human-derived Casein Kinase I alpha protein, expressed by Sf9 insect cells , with N-GST labeled tag.

HY-P702668

	CSNK1A1 Protein, Human (sf9, His, Strep) CSNK1A1; casein kinase 1, alpha 1; casein kinase I isoform alpha; CK1; CK1a; CK1alpha; CKIa; CKIalpha; cloCK regulator kinase; CKI-alpha; down-regulated in lung cancer; HLCDGP1; PRO2975	Human	Sf9 insect cells
	Casein kinase I α is a member of casein kinases that exhibits a preference for phosphorylation of acidic proteins such as casein. It phosphorylates many substrates, including CTNNB1 at "Ser-45" involved in Wnt signaling. CSNK1A1 Protein, Human (sf9, His, Strep) is the recombinant human-derived CSNK1A1, expressed by Sf9 insect cells, with Strep, His labeled tag. The total length of CSNK1A1 Protein, Human (sf9, His, Strep) is 336 a.a..

HY-P702670

	CSNK1A1L Protein, Human (sf9, His, GST) CSNK1A1L; casein kinase 1, alpha 1-like; casein kinase I isoform alpha-like; MGC33182; CKI-alpha-like; casein kinase I alpha S-like; CK1	Human	Sf9 insect cells
	CSNK1A1L Protein, Human (sf9, His, GST) is the recombinant human-derived CSNK1A1L, expressed by Sf9 insect cells , with His, GST labeled tag.

HY-P704195

	CSNK1E Protein, Human (Active, sf9, GST) Casein kinase 1 epsilon; Casein kinase I; Casein kinase I epsilon; Casein kinase I isoform epsilon; CKI epsilon; CKI-epsilon; CKIe; CKIepsilon; CSNK 1E; CSNK1E; DBT; Doubletime, Drosophila, homolog of; EC 2.7.11.1; epsilon isoform; HCK IE; KC1E; KC1E_HUMAN; kinase CK1 epsilon; MGC 10398	Human	Sf9 insect cells
	CSNK1E protein is a casein kinase that preferentially phosphorylates acidic proteins such as casein. CSNK1E Protein, Human (Active, sf9, GST) is the recombinant human-derived CSNK1E protein, expressed by Sf9 insect cells, with N-GST labeled tag.

HY-P702667

	CSNK1G2 Protein, Human (sf9, GST) CSNK1G2; casein kinase 1 gamma 2; CK1g2	Human	Sf9 insect cells
	Casein kinase I gamma-2 is a serine/threonine protein kinase that targets acidic proteins and phosphorylates a variety of substrates, such as COL4A3BP/CERT, MTA1 and SMAD3, especially destabilizing SMAD3 and inhibiting TGF- beta reaction. Hyperphosphorylation of COL4A3BP/CERT disrupts ER-to-Golgi transport and affects the synthesis of ceramide and sphingomyelin. CSNK1G2 Protein, Human (sf9, GST) is the recombinant human-derived CSNK1G2, expressed by Sf9 insect cells, with GST labeled tag. The total length of CSNK1G2 Protein, Human (sf9, GST) is 414 a.a..

HY-P7741

	Casein Kinase I gamma-2 Protein, Human (His) rHuCasein kinase I isoform gamma-2, His; Casein kinase I isoform gamma-2; CK1G2; CSNK1G2	Human	E. coli
	Casein kinase I gamma-2 Protein, Human (His) is an approximately 55.0 kDa human casein kinase I isoform gamma-2 protein with a His-flag expressed in E. coli. Human Casein kinase I isoform gamma-2 may exhibit overexpression during tumorigenesis and belongs to the CKI family.

HY-P72873

	Casein Kinase I gamma-2 Protein, Human (sf9, His) Casein kinase I isoform gamma-2; CKI-gamma 2; CSNK1G2; CK1G2	Human	Sf9 insect cells
	Casein kinase I gamma-2 is a serine/threonine protein kinase that targets acidic proteins and phosphorylates a variety of substrates, such as COL4A3BP/CERT, MTA1 and SMAD3, especially destabilizing SMAD3 and inhibiting TGF- beta reaction. Hyperphosphorylation of COL4A3BP/CERT disrupts ER-to-Golgi transport and affects the synthesis of ceramide and sphingomyelin. Casein Kinase I gamma-2 Protein, Human (sf9, His) is the recombinant human-derived Casein Kinase I gamma-2 protein, expressed by Sf9 insect cells , with N-His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80585

	Casein Kinase 1 alpha Antibody (YA564) CSNK1A1; Casein kinase I isoform alpha; CKI-alpha; CK1	WB, IP	Human, Rat
	Casein Kinase 1 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Casein Kinase 1 alpha. It can be used for WB,IP assays with tag free, in the background of Human, Rat.

HY-P82920

	Cytokeratin 1 Antibody (YA2665) 67 kDa cytokeratin; CK1; EHK; Epidermolytic hyperkeratosis 1; EPPK; Hair alpha protein; K1; Keratin; KRT 1; KRT1A; NEPPK; type II cytoskeletal 1; Type-II keratin Kb1	WB	Human, Mouse, Rat
	Cytokeratin 1 Antibody (YA2665) is a non-conjugated IgG antibody, targeting Cytokeratin 1, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). Cytokeratin 1 Antibody (YA2665) can be used for WB experiment in human, mouse, rat background.

HY-P85075

	Casein Kinase Iα Antibody (YA4767) CSNK1A1; Casein kinase I isoform alpha; CKI-alpha; CK1	WB, IHC-P, ICC/IF, ELISA	Human
	Casein Kinase Iα Antibody (YA4767) is a mouse-derived and non-conjugated monoclonal antibody, targeting to Casein Kinase Iα. It can be applicated for WB, IHC-P, ICC/IF, ELISA assays, in the background of human.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks